Health Canada has given Medtronic Canada approval for its line of MRI-conditional cardiac resynchronization therapy defibrillators, which include the Compia MRI Quad CRT-D SureScan and Amplia MRI Quad CRT-D SureScan systems. With the approval, the devices, which can work with the company's Attain Performa MRI SureScan quadripolar leads, can now be used for MRI scans on any body part without restrictions to positioning.
Canada OKs Medtronic's line of MRI-conditional CRT-Ds
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.